| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 10/23/2008 | US20080262745 Method for Determining Insulin Sensitivity and Glucose Absorption |
| 10/23/2008 | US20080262743 Methods for remote characterization of an odor |
| 10/23/2008 | US20080262742 Computational method and apparatus for predicting polypeptide aggregation or solubility |
| 10/23/2008 | US20080262741 Method and apparatus for screening chemical compounds |
| 10/23/2008 | US20080262740 Permittivity-based material sensor |
| 10/23/2008 | US20080262334 Method and device for predicting physiological values |
| 10/23/2008 | US20080262321 Early Detection of Harmful Agents: Method, System and Kit |
| 10/23/2008 | US20080262211 Hepatitis-c virus type 4, 5 and 6 |
| 10/23/2008 | US20080262206 Method of Isolating Proteon Nucleation Centers from Blood and Other Biological Materials |
| 10/23/2008 | US20080262204 A purified affinity-matured antibody or a portion thereof having binding specificity for 83 kDa protective antigen (PA83) of Bacillus anthracis; confers protection to a host against a tripartite toxin of Bacillus anthracis; cloned from an anti-Bacillus anthracis PA83 hybridoma |
| 10/23/2008 | US20080262201 Method and a system for predicting protein functional site, a method for improving protein function, and a function-modified protein |
| 10/23/2008 | US20080262108 Screening for active modulators with binding affinity of Carboxyl Ester Lipase(CEL)(cholesterol esterase) to receptors for the prevention/treatment of atherosclerosis; immunohistochemistry; screening/biological/; reducing the retention of atherogenic lipoproteins in atherogenesis; mechanism of action |
| 10/23/2008 | US20080262093 Contacting a cell expressing PGC-1 with various amount of respiration uncoupling agent to determing the resulting maximum PGC-1 level and therefore the upper limit of the safe dosage for the agent; decreasing fat mass/adipocity or increasing weight loss; antidiabetic agents; eating/metabolic disorders |
| 10/23/2008 | US20080262087 Modified g-protein coupled receptor for identifying modulators of taste preception; artificial sweeteners |
| 10/23/2008 | US20080262011 N-(2-hydroxy-1-methyl-ethyl)-3-iodobenzamide; for the treatment of a muscular disorder, a gastrointestinal disorder, or for controlling spasticity or tremors; modulates cannabinoid receptors |
| 10/23/2008 | US20080261910 Diagnostic Methods Based on Polymorphisms of Glucosyltransferase-Like Protein |
| 10/23/2008 | US20080261903 Isolated polynucleotide encoding a Regulated in chronic obstructive pulmonary disease Kinase polypeptide; host cell; hybridization; screening; prediction, diagnosis; prognosis; chronic obstructive pulmonary disease, asthma, cancer, diseases of defective cell signaling |
| 10/23/2008 | US20080261889 Using variation in mannan-binding lectin (MBL) gene as diagnostic/prognostic indicator; Alzheimer's disease |
| 10/23/2008 | US20080261883 Runx3 gene showing anti-tumor activity and use thereof |
| 10/23/2008 | US20080261882 Methods for Inhibiting Heregulin and Treating Cancer |
| 10/23/2008 | US20080261879 Activin (follistatin) receptors; inhibin; neuronal differentiation; transforming growth factors |
| 10/23/2008 | US20080261862 Integrin mediates proliferative signal provided by CD23 to pre-B cells; immobilized rodent cells; drug screening; anticancer agents; antiinflammatory agents |
| 10/23/2008 | US20080261833 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| 10/23/2008 | US20080261831 Ligands and libraries of ligands |
| 10/23/2008 | US20080261829 specificity associated with enzyme-linked immunosorbent assays, sensitivity associated with signal amplification, and high-throughput multiplexing associated with microarrays; superior dynamic range |
| 10/23/2008 | US20080261826 Manufacture And Use Of Non-Standard Size Microarray Slides |
| 10/23/2008 | US20080261825 By contacting with a sol gel precursor such as diglycerylsilane that is compatible with said membrane-associated molecule such as ion channel proteins, ionophores, G-protein coupled receptors and allowing a gel to form; use in screening for drugs or drug targets, biosensors, microarrays |
| 10/23/2008 | US20080261823 Fluorescent Nucleoside Analogs That Mimic Naturally Occurring Nucleosides |
| 10/23/2008 | US20080261822 Non-invasive prenatal genetic diagnosis using transcervical cells |
| 10/23/2008 | US20080261821 Provides method of detecting an active kinase in a sample; the method includes contacting an array of immobilized interactors with a mechanism-based crosslinker and a sample comprising an active kinase; immobilized crosslinked kinase-interactor pair is thereby formed, detecting active kinase |
| 10/23/2008 | US20080261330 Apparatus Components and Methods of Using Apparatus Components to Detect the Presence of an Analyte |
| 10/23/2008 | US20080261329 Method of analysis of a mixture of biological and/or chemical components with the use magnetic particles and apparatus for its embodiment |
| 10/23/2008 | US20080261328 Using dispersion liquid comprising dextran, cyclodextrin, polyethlyene glycol and/or glycerol to prevent precipitation of bound antibody and/or antigen in immunoassay; enhancing accuracy of bioassay detection |
| 10/23/2008 | US20080261327 Cell Free Assay for Determining a Substance of Interest and Molecular Complexes Used Therefore |
| 10/23/2008 | US20080261326 Drop-on-demand manufacturing of diagnostic test strips |
| 10/23/2008 | US20080261322 Nitric Oxide Detection |
| 10/23/2008 | US20080261321 Methods and Compositions for Detecting and Isolating Phosphorylated Molecules Using Hydrated Metal Oxides |
| 10/23/2008 | US20080261320 Using electromagnetic wave, acoustic wave, electrical characteristics, optical rotation and/or absorbance or reflectivity of infrared light or visible light to determine glucose concentration of blood; pain and infection management treating diabetes |
| 10/23/2008 | US20080261319 Method for detecting presence of aristolochia materials in herbal products and botanicals |
| 10/23/2008 | US20080261318 Signalling Compounds For Use In Methods Of Detecting Hydrogen Peroxide |
| 10/23/2008 | US20080261317 Methods of Detecting Myocardial Ischemia and Myocardial Infarction |
| 10/23/2008 | US20080261316 Compositions and Methods For Enhancing the Identification of Prior Protein Prpsc |
| 10/23/2008 | US20080261315 High speed, accurate, direct assay of human blood |
| 10/23/2008 | US20080261314 Fluorescent probe for zinc |
| 10/23/2008 | US20080261313 Apo B measurement system and method |
| 10/23/2008 | US20080261312 Methods for matrix cleanup and analysis of drugs and metabolites in biological matrices |
| 10/23/2008 | US20080261302 Nucleotide sequences coding seladin-1polypeptide for use in treatment and prevention of alzheimer's disease |
| 10/23/2008 | US20080261270 Expression vector comprising nucleotide sequences estrogen receptor protein for use in inhibition of heregulin binding and treatment of breast and prostate cancers |
| 10/23/2008 | US20080261257 Fluorescent Proteins and Related Methods and Compounds |
| 10/23/2008 | US20080261255 Reporter molecule comprising anilino-naphthalene sulfonate and ruthenium complex for use in determining concentration of protein in solutions |
| 10/23/2008 | US20080261254 Procedure for the determination of the reaction lag phase in an analyte-dependent reaction |
| 10/23/2008 | US20080261253 Methods and kits for the diagnosis of galactosemia |
| 10/23/2008 | US20080261252 Soluble Interleukin-1 Receptor Accessory Molecule |
| 10/23/2008 | US20080261251 Monoclonal Antibodies, Hybridomas, Improved Method for Determining the Protein Ptx3 and Kit for Said Determination |
| 10/23/2008 | US20080261250 Detecting presence of HDL oxidation product such as nitrotyrosine; ELISA; kits |
| 10/23/2008 | US20080261249 Using bead immobilized immunoglobulin to capture and separate host cell protein from genetically engineered translational products |
| 10/23/2008 | US20080261248 Method of detecting red cell antigen-antibody reactions |
| 10/23/2008 | US20080261247 Incubating erythrocytes, test sample and low ionic strength medium containing polyvinylpyrrolidone to optimize antibody uptake, mixing with hexadimethrine bromide for agglutination, separating, neutralizing with glycosaminoglycan, monitoring for antibodies, then stabilizing; kits |
| 10/23/2008 | US20080261246 Tissue inhibitor of matrix metalloproteinases type-1 (timp-1) as a cancer marker and postoperative marker for minimal residual disease or recurrent disease in patients with a prior history of cancer |
| 10/23/2008 | US20080261245 Antibodies, including fv molecules, and immunoconjugates having high binding affinity for mesothelin and methods for their use |
| 10/23/2008 | US20080261244 Compositions And Methods For Treating And Diagnosing Pancreatic Cancer |
| 10/23/2008 | US20080261243 Detection of Elevated Levels of Her-2/Neu Protein on Circulating Cancer Cells and Treatment |
| 10/23/2008 | US20080261242 Mixture comprising cardiac muscle protein specific immunoglobulin for use diagnosing/prognosing cardiovascular disorders |
| 10/23/2008 | US20080261241 Targeted ubiquitination of proteins and screening methods using a new class of ubiquitin ligase proteins |
| 10/23/2008 | US20080261240 Method |
| 10/23/2008 | US20080261239 Fluorescence resonance energy transfer; drug screening; kits |
| 10/23/2008 | US20080261238 Method for Differentiation of Factor XIII Deficiency States in Relation to Fibrinogen Deficiency States Using Thrombelastographic Techniques |
| 10/23/2008 | US20080261237 Inositol-Phosphate Derivatives and Method of Detecting Inositol-1-Phosphate |
| 10/23/2008 | US20080261236 FGF21 upregulates expression of GLUT-1 in a beta Klotho-dependent manner |
| 10/23/2008 | US20080261235 Novel Green and Orange Fluorescent Labels and Their Uses |
| 10/23/2008 | US20080261234 Peptides and their use in assays for cardiovascular disease |
| 10/23/2008 | US20080261233 Assessment of Biological Activity of Hepatocyte Growth Factor (Hgf) |
| 10/23/2008 | US20080261232 Use of Precursors of Enkephalins and/or Their Fragments in Medical Diagnostics |
| 10/23/2008 | US20080261231 Nucleotide sequences coding angiotensinogen (AGT) gene for use as evaluative tool in diagnosing pancreatic disorders; disease screening through genomic variance |
| 10/23/2008 | US20080261228 Using prostate cancer antigen (PCA) expression as evaluative tool in diagnosis/prognosis of cancer |
| 10/23/2008 | US20080261226 Biomarkers of neurodegenerative disease |
| 10/23/2008 | US20080261224 PGC-1Beta, A Novel PGC-1 Homologue and Uses Therefor |
| 10/23/2008 | US20080261223 Aldo-keto reductase specific immunoglobulin for use in diagnosis, classification and imaging of cell proliferative disorders |
| 10/23/2008 | US20080261216 Using human endogenous retrovirus (HERVs) expression as evaluative tool in diagnosis/prognosis of cell proliferative disorders |
| 10/23/2008 | US20080261215 Using allergen mediator expression as evaluative tool in prediciting allergic response to birch and/or grass pollens, mites and bee allergens; immunotherapy |
| 10/23/2008 | US20080261213 Assay |
| 10/23/2008 | US20080261211 Using polymorphic variation in complement cascade genes as evaluative tool in prognosis/diagnosis of vision defects |
| 10/23/2008 | US20080261210 Using colorimetric analysis to determine plasma homocysteine concentration in blood |
| 10/23/2008 | US20080261204 Using coded probes to quantify absolute or relative number of molecules pool after DNA amplification |
| 10/23/2008 | US20080261202 Hydrogen ion concentration sensitive probe for use as screening tool in biopolymer detection |
| 10/23/2008 | US20080261199 Rapid detection processes and related compositions |
| 10/23/2008 | US20080261197 O retroviral protein for use as tool in detection, treatment and prevention of human immunodeficiency virus infection |
| 10/23/2008 | US20080260839 Stable, high porosity silicon microparticle aerosol carriers derived from semiconductor p+ wafers; resorbable and/or photoluminescent |
| 10/23/2008 | US20080260789 Expressed in venom glands of spiders; polynucleotides; transgenic plant or insect |
| 10/23/2008 | US20080260768 Streptococcus pneumoniae proteins and nucleic acid molecules |
| 10/23/2008 | US20080260767 Novel Protein Which can be Used, in Particular, for the In Vitro Isolation and Prevention of Legionella Pneumophila Infections |
| 10/23/2008 | US20080260763 High Throughput Proteomics |
| 10/23/2008 | US20080260761 Compositions, Splice Variants and Methods Relating to Cancer Specific Genes and Proteins |
| 10/23/2008 | US20080260760 Nucleotide sequences coding prostate-specific antigen-derived peptide for use as vaccine inntreatment of urogenital cell proliferative disorders |
| 10/23/2008 | US20080260759 Novel Mite Allergen |
| 10/23/2008 | US20080260756 Peptide Inhibitors of iASPP |
| 10/23/2008 | US20080260753 Transgenic animal model expressing NOD mutant for use in identifying modulator for treatment of inflammatory bowel disease |
| 10/23/2008 | US20080260751 Using activator of toll like receptor-4 protein as therapeutic in treatment and prevention of arthritic, inflammatory, kidney, skin bone, respiratory, brain, cell proliferative and liver disorders |
| 10/23/2008 | US20080260750 Polynucleotides Encoding Acetylcholine-Gated Chloride Channel Subunits of Caenorhabditis Elegans |
| 10/23/2008 | US20080260747 Adhesion interaction protein (CD-84) specific immunoglobulin for use in the treatment of cell proliferative disorders of the blood |